Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy
10.2217/fon.12.53
Saved in:
Main Authors: | Zee, Y.-K., Goh, B.-C., Lee, S.-C. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Review |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117353 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Genetic polymorphisms and CYP2D6 activity in Thai subjects
by: Payiarat Nakmahachalasint
Published: (2006) -
EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
by: TEO YI LING
Published: (2015) -
Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: Profiling and comparison of two drug compendia
by: Wong, C.-M., et al.
Published: (2014) -
Effect of phenytoin on the pharmacokinetics of efavirenz in rabbits
by: Gornganok Piboonpol
Published: (2013) -
Drug disposition : concepts and applications
by: Amnuay Thithapandha
Published: (2014)